Immunohistochemical expression of procaspase-3 and its clinical significance in childhood non-Hodgkin lymphomas

Pediatric and Developmental Pathology

Volumn 14, Issue 3, 2011, Pages 173-179

  Wrobel, Grazyna ^a   Maldyk, Jadwiga ^b   Kazanowska, Bernarda ^a   Rapala, Malgorzata ^a   Maciejka Kapuscinska, Lucyna ^c   Chaber, Radosaw ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Children; Non Hodgkin lymphoma; Procaspase 3; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; FORMALDEHYDE; PARAFFIN; PROCASPASE 3; CASP3 PROTEIN, HUMAN; CASPASE 3; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BIOPSY; BIOSYNTHESIS; CANCER STAGING; DISEASE FREE SURVIVAL; DRUG RESISTANCE; ENZYMOLOGY; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY; PHYSIOLOGY;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASPASE 3; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80054017688     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/10-01-0779-OA.1     Document Type: Article

References (27)

1. Reiter A. Diagnosis and treatment of childhood non-Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2007:285-296.
2. Le Deley MC, Reiter A, Williams D, et al. Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood 2008;111:1560-1566. (Pubitemid 351213446)
3. Burkhardt B, Zimmermann M, Oschlies I, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 2005;131:39-49. (Pubitemid 43899706)
4. Oudejans JJ, Harijadi A, Cillessen SA, et al. Absence of caspase-3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome. Mod Pathol 2005;18:877-885. (Pubitemid 41059946)
5. Schimmer AD, Pedersen IM, Kitada S, et al. Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy. Cancer Res 2003;63:124221248.
6. Anwar S, Ambros R, Jennings TA, et al. Expression of cysteine protease protein 32 in prostatic adenocarcinoma correlates with tumor grade. Arch Pathol Lab Med 2004;128:649-652. (Pubitemid 41490425)
7. Krajewska M, Wang HG, Krajewski S, et al. Immunohistochemical analysis of in vivo patterns expression of CPP32/caspase-3/, a cell death protease. Cancer Res 1997;57:1605-1613. (Pubitemid 27175582)
8. Krajewski S, Gascoyne RD, Zapata JM, et al. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemia, and reactive lymph nodes. Blood 1997;89:3817-3825. (Pubitemid 27227107)
9. Xerri L, Devilard E, Ayello C, et al. Cysteine protease CPP32, but not Ich1-L, is expressed in germinal center B cells and their neoplastic counterparts. Hum Pathol 1997;28:912-921. (Pubitemid 27355551)
10. Durkop H, Hirsch B, Hahn C, Stein H. cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3. J Mol Med 2006;84:1432-1440.
11. ten Berge RL, Meijer CJLM, Dukers DF, et al. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood 2002;99:4540-4546. (Pubitemid 34627225)
12. Drakos E, Rassidakis GZ, Lai R, et al. Caspase-3 activation in systemic anaplastic large-cell lymphoma. Mod Pahol 2004;17:109-116. (Pubitemid 41656460)
13. Muris JJF, Cillessen SAGM, Vos W, et al. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. Blood 2005;105:2916-2923. (Pubitemid 40446286)
14. Li HL, Sun BZ, Feng Q, Shang ZC. Expression of surviving and caspase-3 in non-Hodgkin's lymphoma and their clinical significance. Ai Zheng 2004;23:40-43.
15. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: IARC, 2008.
16. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1980;7:332-339. (Pubitemid 11228642)
17. Kaplan EI, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
18. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-776.
19. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316. (Pubitemid 28406817)
20. Mancini M, Nicholson DW, Roy S, et al. The capase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol 1998;140:1485-1495. (Pubitemid 28152996)
21. Stennicke HR, Jurgeusmeier JM, Shin H, et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998;273:27084-27090. (Pubitemid 28500413)
22. Arai M, Sasaki A, Saito N, Nakazato Y. Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system. Pathol Int 2005;55:122-129. (Pubitemid 40477223)
23. Dukers DF, Oudejans JJ, Vos W, ten Berge RL, Meijer CJLM. Apoptosis in B-cell lymphomas and reactive lymphoid tissue always involves activation of caspase-3 as determined by a new in situ detection method. J Pathol 2002;196:307-315. (Pubitemid 34189420)
24. Elsawy WH, Abdel Kader M, Elfar A, Gharib A, Eltrhony S, Dorgham Y. Prognostic implications of caspase-3 expression in patients with diffuse large B-cell lymphoma (DLBCL) [ASCO abstract, post-meeting edition]. J Clin Oncol 2006;24(Suppl):17500.
25. Mourali J, Benard A, Lourenco FC, et al. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol 2006;26:6209-6222. (Pubitemid 44204538)
26. Oyarzo MP, Drakos E, Atwell C, Amin HM, Medeiros LJ, Rassidakis GZ. Intrinsic apoptotic pathway in anaplastic large cell lymphoma. Hum Pathol 2006;37:874-882. (Pubitemid 43902949)
27. Atkinson EA, Barry M, Darmon AJ, et al. Cytotoxic T lymphocyte-assisted suicide: caspase-3 activation is primarily the result of the direct action of granzyme B. J Biol Chem 1998;273:21261-21266. (Pubitemid 28385418)